XENE Stock Summary and Trading Ideas (Xenon Pharmaceuticals - Common Shares | NASDAQ:XENE)

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

Xenon Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol XENE.

As of May 13, 2024, XENE stock price declined to $40.48 with 288,974 million shares trading.

XENE has a beta of 0.95, meaning it tends to be less sensitive to market movements. XENE has a correlation of 0.08 to the broad based SPY ETF.

XENE has a market cap of $3.05 billion. This is considered a Mid Cap stock.

In the last 3 years, XENE stock traded as high as $50.99 and as low as $14.65.

The top ETF exchange traded funds that XENE belongs to (by Net Assets): IBB, VHT, PBE, DFAS, SPDW.

XENE has underperformed the market in the last year with a price return of -1.6% while the SPY ETF gained +27.8%. XENE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -19.1% and 0.0%, respectively, while the SPY returned +4.3% and +2.5%, respectively.

XENE support price is $39.47 and resistance is $41.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XENE stock will trade within this expected range on the day.